DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Virtual Event

2020 年 05 月 18 日 10:00 上午 - 2020 年 05 月 20 日 3:15 下午

(US Eastern Standard Time)

Fort Washington, PA 19034

Advertising and Promotion Regulatory Affairs Conference

Session 3: OPDP Research Update (Recorded)

Session Chair(s)

Kathryn  Aikin, PhD, MS

Kathryn Aikin, PhD, MS

Senior Social Science Analyst, Research Team Lead, OPDP, CDER

FDA, United States

Individual FDA/OPDP researchers will present findings from OPDP research studies. Attendees will gain a better understanding of the FDA/OPDP Research program and how it may contribute to knowledge, guidance, and policy development. This session is designed to educate attendees on the regulatory research FDA has done to help inform policy and guidance development.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand the holistic research agenda of FDA/OPDP
  • Provide the audience with a view into individual topic areas and how they fit together
  • Identify insight into results of recent research

Speaker(s)

Kathryn  Aikin, PhD, MS

Introduction to the OPDP Research Program

Kathryn Aikin, PhD, MS

FDA, United States

Senior Social Science Analyst, Research Team Lead, OPDP, CDER

Amie  O'Donoghue, PhD

Animation in Direct-to-Consumer Prescription Drug Television Advertising

Amie O'Donoghue, PhD

FDA, United States

Social Science Analyst, OPDP, OMP, CDER

Kevin R. Betts, PhD

Physician and Consumer Capability to Detect and Inclination to Report Deceptive Prescription Drug Promotion

Kevin R. Betts, PhD

FDA, United States

Social Science Analyst, OPDP, OMP, CDER

Helen W. Sullivan, PhD, MPH

Consumers’ Understanding of Oncology Clinical Endpoints: Focus Group Findings

Helen W. Sullivan, PhD, MPH

FDA, United States

Social Science Analyst, OPDP, OMP, CDER

Kathryn  Aikin, PhD, MS

Consumers’ Experience with and Attitudes Toward Direct-to-Consumer Prescription Drug Promotion: A Nationally Representative Survey - Selected Findings

Kathryn Aikin, PhD, MS

FDA, United States

Senior Social Science Analyst, Research Team Lead, OPDP, CDER

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。